SUMO-specific protease 1 promotes prostate cancer progression and metastasis (Q39325271)

11 September 2017

SUMO-specific protease 1 promotes prostate cancer progression and metastasis (English)

1 reference

11 September 2017

1 reference

Q Wang

1

1 reference

11 September 2017

N Xia

2

1 reference

11 September 2017

T Li

3

1 reference

11 September 2017

Y Xu

4

1 reference

11 September 2017

Y Zou

5

1 reference

11 September 2017

Y Zuo

6

1 reference

11 September 2017

Q Fan

7

1 reference

11 September 2017

T Bawa-Khalfe

8

1 reference

11 September 2017

E T H Yeh

9

1 reference

11 September 2017

J Cheng

10

1 reference

11 September 2017

language of work or name

English

0 references

publication date

25 June 2012

1 reference

11 September 2017

1 reference

11 September 2017

32

1 reference

11 September 2017

19

1 reference

11 September 2017

2493-2498

1 reference

https://scigraph.springernature.com/pub.10.1038/onc.2012.250

11 September 2017

0 references

cites work

SUMOylation and De-SUMOylation: wrestling with life's processes

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.250

SUMO: a history of modification

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.250

Roles of sumoylation of a reptin chromatin-remodelling complex in cancer metastasis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.250

SIRT1 sumoylation regulates its deacetylase activity and cellular response to genotoxic stress

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.250

SENP1-mediated GATA1 deSUMOylation is critical for definitive erythropoiesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.250

SENP1 enhances androgen receptor-dependent transcription through desumoylation of histone deacetylase 1

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.250

SUMO-specific protease 1 is essential for stabilization of HIF1alpha during hypoxia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.250

SUMO-specific protease 1 (SENP1) reverses the hormone-augmented SUMOylation of androgen receptor and modulates gene responses in prostate cancer cells.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.250

Mutation of SENP1/SuPr-2 reveals an essential role for desumoylation in mouse development.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.250

Induction of the SUMO-specific protease 1 transcription by the androgen receptor in prostate cancer cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.250

Role of desumoylation in the development of prostate cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.250

SENP1 induces prostatic intraepithelial neoplasia through multiple mechanisms

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.250

Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.250

Matrix metalloproteinase activity, bone matrix turnover, and tumor cell proliferation in prostate cancer bone metastasis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.250

Matrix metalloproteinases: regulators of the tumor microenvironment

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.250

Matrix metalloproteinases contribute distinct roles in neuroendocrine prostate carcinogenesis, metastasis, and angiogenesis progression

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.250

Serum matrix metalloproteinase-2 and its density in men with prostate cancer as a new predictor of disease extension

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.250

Application of histone modification in the risk prediction of the biochemical recurrence after radical prostatectomy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.250

The transcription factors Sp1, Sp3, and AP-2 are required for constitutive matrix metalloproteinase-2 gene expression in astroglioma cells.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.250

Induction of SENP1 in endothelial cells contributes to hypoxia-driven VEGF expression and angiogenesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.250

31 March 2020

Identifiers

DOI

10.1038/ONC.2012.250

1 reference

11 September 2017

1 reference